GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Brokerages

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $86.8889.

GEHC has been the topic of several recent analyst reports. BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Citigroup increased their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th.

GE HealthCare Technologies Trading Down 0.3%

GE HealthCare Technologies stock opened at $76.56 on Friday. GE HealthCare Technologies has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $34.95 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 2.93 and a beta of 1.13. The firm has a 50-day moving average price of $74.25 and a two-hundred day moving average price of $72.54.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is 2.87%.

Hedge Funds Weigh In On GE HealthCare Technologies

Hedge funds have recently modified their holdings of the company. NBC Securities Inc. acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at $43,000. Merit Financial Group LLC raised its position in GE HealthCare Technologies by 16.0% in the first quarter. Merit Financial Group LLC now owns 10,232 shares of the company’s stock worth $826,000 after acquiring an additional 1,412 shares in the last quarter. Breakwater Capital Group bought a new stake in GE HealthCare Technologies in the first quarter worth about $210,000. Signal Advisors Wealth LLC boosted its position in shares of GE HealthCare Technologies by 2.7% during the 1st quarter. Signal Advisors Wealth LLC now owns 14,137 shares of the company’s stock valued at $1,141,000 after purchasing an additional 373 shares in the last quarter. Finally, Procyon Advisors LLC boosted its position in shares of GE HealthCare Technologies by 78.2% during the 1st quarter. Procyon Advisors LLC now owns 4,992 shares of the company’s stock valued at $403,000 after purchasing an additional 2,191 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.